Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC — Stella

Home/Carcinoma, Non-Small-Cell Lung/

View on ClinicalTrials.gov

Recruiting

Back to Carcinoma, Non-Small-Cell Lung trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Taiwan

Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

Key details

Phase

Safety & dosing

Sponsor

Taipei Veterans General Hospital, Taiwan

Enrollment target

~23 participants

Started

August 2024

Primary completion

December 2026

Age range

20 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.